We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · November 14, 2019

Skin Reaction Associated With Clinical Benefit in Patients With Advanced NSCLC Treated With Anti–PD-1 Monotherapy

The Oncologist

 

Additional Info

The Oncologist
Association Between Skin Reaction and Clinical Benefit in Patients Treated With Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung Cancer
Oncologist 2019 Nov 07;[EPub Ahead of Print], M Aso, Y Toi, J Sugisaka, T Aiba, S Kawana, R Saito, T Ogasawara, K Tsurumi, K Ono, H Shimizu, Y Domeki, K Terayama, Y Kawashima, A Nakamura, S Yamanda, Y Kimura, Y Honda, S Sugawara

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading